ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,700,000 | +58.6% | 50,564 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $2,964,000 | +13.0% | 49,764 | +29.4% | 0.00% | 0.0% |
| Q2 2021 | $2,623,000 | -3.7% | 38,467 | -2.0% | 0.00% | 0.0% |
| Q1 2021 | $2,724,000 | +2.8% | 39,245 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $2,650,000 | +1.5% | 34,491 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $2,612,000 | +24.3% | 34,926 | +4.6% | 0.00% | 0.0% |
| Q2 2020 | $2,102,000 | +44.8% | 33,393 | -3.4% | 0.00% | 0.0% |
| Q1 2020 | $1,452,000 | -11.1% | 34,564 | -3.8% | 0.00% | 0.0% |
| Q4 2019 | $1,633,000 | +22.0% | 35,943 | +22.8% | 0.00% | 0.0% |
| Q3 2019 | $1,339,000 | -11.5% | 29,264 | +13.4% | 0.00% | 0.0% |
| Q2 2019 | $1,513,000 | +66.6% | 25,796 | +27.3% | 0.00% | 0.0% |
| Q1 2019 | $908,000 | +17.5% | 20,266 | +2.1% | 0.00% | 0.0% |
| Q4 2018 | $773,000 | -9.9% | 19,852 | +6.5% | 0.00% | 0.0% |
| Q3 2018 | $858,000 | +147.3% | 18,634 | +134.5% | 0.00% | – |
| Q2 2018 | $347,000 | +0.6% | 7,946 | -9.1% | 0.00% | – |
| Q1 2018 | $345,000 | +2.4% | 8,743 | -11.6% | 0.00% | – |
| Q4 2017 | $337,000 | +27.7% | 9,894 | -4.5% | 0.00% | – |
| Q3 2017 | $264,000 | +125.6% | 10,356 | +46.8% | 0.00% | – |
| Q2 2017 | $117,000 | – | 7,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |